메뉴 건너뛰기




Volumn 64, Issue 7, 2005, Pages 1101-1106

PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it

(37)  Ruperto, N a,ah   Garcia Munitis, P a   Villa, L a   Pesce, M a   Aggarwal, A b   Fasth, A c   Avcin, T d   Bae, S C e   Balogh, Z f   Li, C g   De Inocencio, J h   Dibra, M i   Dolezalova, P j   El Miedany, Y k   Flato, B l   Harjacek, M m   Huppertz, H I h   Kanakoudi Tsakalidou, F n   Wulffraat, N o   Landenne, P p   more..

a PRINTO   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHILDHOOD DISEASE; FAMILY; HEALTH CARE PERSONNEL; HUMAN; INTERNET; LANGUAGE; MEDICAL INFORMATION SYSTEM; MEDICAL RESEARCH; ORGANIZATION; PEDIATRICIAN; PRIORITY JOURNAL; RHEUMATIC DISEASE; SELF HELP;

EID: 21344466317     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.030221     Document Type: Article
Times cited : (27)

References (12)
  • 1
    • 3242775459 scopus 로고    scopus 로고
    • eEurope 2002: Quality criteria for health related websites
    • Commission of the European Communities, Brussels, Belgium. eEurope 2002: quality criteria for health related websites. J Med Internet Res 2002;4:e15.
    • (2002) J Med Internet Res , vol.4
  • 2
    • 0034701282 scopus 로고    scopus 로고
    • Guidelines for medical and health information sites on the internet - Principles governing AMA web sites
    • Winker MA, Flanagin A, Chi-Lum B, White J, Andrews K, Kennett RL, et al. Guidelines for medical and health information sites on the internet - principles governing AMA web sites. JAMA 2000;283:1600-6.
    • (2000) JAMA , vol.283 , pp. 1600-1606
    • Winker, M.A.1    Flanagin, A.2    Chi-Lum, B.3    White, J.4    Andrews, K.5    Kennett, R.L.6
  • 3
    • 4344638042 scopus 로고    scopus 로고
    • International research networks in pediatric rheumatology: The PRINTO perspective
    • Ruperto N, Martini A. International research networks in pediatric rheumatology: the PRINTO perspective. Curr Opin Rheumatol 2004;16:566-70.
    • (2004) Curr Opin Rheumatol , vol.16 , pp. 566-570
    • Ruperto, N.1    Martini, A.2
  • 5
    • 0033600435 scopus 로고    scopus 로고
    • Clinical trials, consensus conferences, and clinical practice
    • Sniderman AD. Clinical trials, consensus conferences, and clinical practice. Lancet 1999;354:327-30.
    • (1999) Lancet , vol.354 , pp. 327-330
    • Sniderman, A.D.1
  • 7
    • 3142718093 scopus 로고    scopus 로고
    • Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis
    • Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003;42:1452-9.
    • (2003) Rheumatology (Oxford) , vol.42 , pp. 1452-1459
    • Ruperto, N.1    Ravelli, A.2    Murray, K.J.3    Lovell, D.J.4    Andersson-Gare, B.5    Feldman, B.M.6
  • 8
    • 0034959826 scopus 로고    scopus 로고
    • Expanding the guideline for electronic communication with patients. Application to a specific tool
    • Prady SL, Norris D, Lester JE, Hoch DB. Expanding the guideline for electronic communication with patients. Application to a specific tool. J Am Med Inform Assoc 2001;8:344-8.
    • (2001) J Am Med Inform Assoc , vol.8 , pp. 344-348
    • Prady, S.L.1    Norris, D.2    Lester, J.E.3    Hoch, D.B.4
  • 9
    • 0032888041 scopus 로고    scopus 로고
    • A look at the future of pediatric therapeutics: An investigator's perspective of the new pediatric rule
    • Connor JD. A look at the future of pediatric therapeutics: an investigator's perspective of the new pediatric rule. Pediatrics 1999;104:610-13.
    • (1999) Pediatrics , vol.104 , pp. 610-613
    • Connor, J.D.1
  • 10
    • 4344618879 scopus 로고    scopus 로고
    • Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biologic products in pediatrics patients (21 CFR Parts 201, 312, 314, and 601)
    • FDA. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biologic products in pediatrics patients (21 CFR Parts 201, 312, 314, and 601). Federal Register 1998:63.
    • (1998) Federal Register , pp. 63
  • 11
    • 85007680228 scopus 로고    scopus 로고
    • Use of unlabelled and off licence drugs in children. A European paediatric rule is needed to protect children
    • Ruperto N, Martini A, for the Paediatric Rheumatology International Trials Organization (PRINTO). Use of unlabelled and off licence drugs in children. A European paediatric rule is needed to protect children. BMJ 2000;320:1210-11.
    • (2000) BMJ , vol.320 , pp. 1210-1211
    • Ruperto, N.1    Martini, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.